Cite

HARVARD Citation

    Nemunaitis, J. et al. (n.d.). Phase 1 dose escalation of ONT-10, a therapeutic MUC1 vaccine, in patients with advanced cancer. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record